Lung Cancer Considered
IASLC
300 episodes
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
More about the show
Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit
Episodes page 2 of 6
-
Lung Cancer Considered: Lung Cancer Care in Areas of Conflict and War
This episode of Lung Cancer Considered, hosted by Dr. Narjust Florez, examines the challenges of delivering lung cancer care in areas affected by war and displacement with guests Dr. Julie Gralow and Dr. Rafal…
-
LCC in Turkish: Virtual Tumor Board Immunotherapy for NSCLC
As part of IASLC’s ongoing series of Lung Cancer Considered podcast episodes in world languages, Dr. Ece Cali moderates a discussion in Turkish with Dr. Irfan Çiçin and Dr. Fulden Yumuk. The episode is part of our…
-
Lung Cancer Considered: IASLC Hot Topic in Basic & Translational Science Meeting Highlights
This episode reviews the IASLC 2025 Hot Topic in Basic and Translational Science Conference, which focused on unraveling precancer and early-stage lung cancer, a theme that really captures where the field is heading.…
-
Lung Cancer Considered in Portuguese: Junior Faculty Perspective
As part of IASLC’s Lung Cancer Considered World Language Series, guest host Dr. Maria Cecilia Mathias leads a discussion in Portuguese about the junior faculty perspective with Dr. Maria Thereza Starling and Dr. Paula…
-
Lung Cancer Considered: Role of General Media in Lung Cancer Research
In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by CNN Medical Correspondent Meg Tirrell and WTOP reporter Neal Augenstein to discuss the role of the media in lung cancer awareness and…
-
Lung Cancer Considered -- Immunotherapy Toxicity: Myths & Pearls
Since the first immunotherapy agent for lung cancer was approved in 2015, this class of drugs has captured the imagination and the narrative for the treatment of driver negative lung cancer. Immunotherapy is now the…
-
Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the science and convenience factor, as well as what this shift means…
-
Lung Cancer Considered at the ASCO IASLC 2025 North American Conference on Lung Cancer
In this special episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the IASLC | ASCO 2025 North America Conference on Lung Cancer. Dr. Igor Odintsov discusses updates in…
-
Lung Cancer Care in New Zealand
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with two thoracic oncologists practicing in New Zealand—Dr. Laird Cameron from Auckland Hospital and Dr. Annie Wong from the University of…
-
LCC in Spanish: Mujeres and oncologia toracica – Latinoamerica
As part of IASLC’s Lung Cancer Considered World Language Series, host Dr. Narjust Florez leads a Spanish-language discussion with three leaders in thoracic oncology across Latin America: Dr. Mónica Castro, Dr. Dolores…
-
IASLC Lung Cancer Considered: ADCs in EGFR Mutant NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Prof. Li Zhang and Dr. Elaine Shum about recent progress in antibody–drug conjugates (ADCs) for EGFR-mutant non-small cell lung cancer…
-
Can I Take That? Integrative Medicine and Lung Cancer
Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between…
-
LCC in Spanish: ¿Pulmón Vital: donde la ciencia se encuentra con la medicina tradicional
As part of IASLC’s Lung Cancer Considered world language series, host Dr. Narjust Florez discusses the role of complementary medicine in cancer care in Spanish with Dr. Cittim Bernardo Palomares and Dr. Eduardo…
-
LCC in Georgian: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
The New Face of Lung Cancer: A Conversation with Two Young Lung Cancer Warriors
In this episode of Lung Cancer Considered, host Dr. Narjust Florez speaks with two remarkable young lung cancer advocates Samantha Murell and Megan Flanagan, who are redefining what it means to live with the disease.…
-
LCC in Hungarian: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
IASLC Lung Cancer Considered: ESMO 2025 Highlights
This episode of Lung Cancer Considered covers highlights from the 2025 ESMO Annual Meeting held October 17th to the 21st in Berlin, Germany. Guests are: Dr. Xiuning Le from MD Anderson Cancer Center in Houston, Texas.…
-
Lung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit
In this episode of Lung Cancer Considered, Dr. Narjust Florez leads a discussion with Ann Fish-Steagall and Amanda Nerstad about the 2025 Lung Cancer Hope Summit. The team discusses highlights from the meeting,…
-
LCC in Greek: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
FDA Approval: Maintenance Lurbinectedin for SCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on the phase III…
-
LCC in Arabic: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
Lung Cancer Considered in Dutch: Targeting EGFR NSCLC
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe Paats and Dr. Gerrina Ruiter on the treatment of EGFR…
-
Lung Cancer Considered: Targeting EGFR NSCLC
Lung Cancer Considered: Targeting EGFR NSCLC by IASLC
-
Lung Cancer Considered in Japanese---2025 WCLC Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
LCC in Korean: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy
This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a…
-
LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
LCC in Portuguese: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens
In this episode, recorded live in Spanish at WCLC 2025, Dr. Diego Carrillo reflects on his experiences as a junior faculty member at WCLC 2025. In conversation with host Dr. Narjust Florez, they discuss conference…
-
LCC in Hebrew: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
Live From WCLC 2025: Tuesday Highlights & Meeting Summary
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the conference. Dr. Susan Scott discusses EGFR mutant NSCLC and results from PALOMA-2…
-
LCC in Spanish: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
Live From WCLC 2025: Monday Highlights
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. Tina Cascone discusses results from the NADIM ADJUVANT Phase…
-
LCC in Mandarin: WCLC 2025 Highlights
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…
-
Live From WCLC 2025: Sunday Highlights
In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. David Planchard discusses the data that we all were waiting…
-
"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees
In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung Cancer (WCLC). Recorded live at WCLC 2025, hear their 10 key…
-
LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC
LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC by IASLC
-
IASLC - ALK Positive Summit
IASLC - ALK Positive Summit by IASLC
-
LCC in Greek: Virtual Tumor Board - ALK NSCLC
LCC in Greek: Virtual Tumor Board - ALK NSCLC by IASLC
-
Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy
Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy by IASLC
-
LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer
LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer by IASLC
-
FDA Approval: Zongertinib for HER2 Mutant NSCLC
FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC
-
LCC in Arabic: Arab Women's Voices in Thoracic Oncology
As part of IASLC’s ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya Khalil. The group discusses the journey and career…
-
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
-
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
-
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC
-
IASLC - Stigma
IASLC - Stigma by IASLC
-
LCC in Japanese: ASCO 2025 Highlights
LCC in Japanese: ASCO 2025 Highlights by IASLC
-
Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer
On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor and Chair of Radiation Oncology at the University of…
-
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
More in Science
Something You Should Know
Mike Carruthers | OmniCast Media
Hidden Brain
Hidden Brain, Shankar Vedantam
Ologies with Alie Ward
Alie Ward
StarTalk with Neil deGrasse Tyson
Neil deGrasse Tyson
Radiolab
WNYC Studios
Big Ideas Lab
Mission.org
Boring History for Sleep
Velvet
Science Vs
Spotify Studios
Science Friday
Science Friday and WNYC Studios
Bite Back with Abbey Sharp
The Roost Podcast Network
Short Wave
NPR
Suspicious Minds: AI and the Apocalypse
Agoric Media
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.